The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2016 | The 2015 World Health Organization classification of lung tumors: A pathologist’s view
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Keith Kerr, BSc, MB ChB, FRCPath, FRCPE, from the University of Aberdeen, Aberdeen, United Kingdom, discusses the 2015 World Health Organization (WHO) Classification of Tumors of the Lung, Pleura, Thymus and Heart. Significant changes include the new classification for small biopsies and cytology and use of immunohistochemistry throughout the classification.
